Bayer's Cash Flow Guidance Looks Soft -- Market Talk

Dow Jones

Mar 05

0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. "We expect a small negative response." Shares rise 1.5% after initially dropping as much as 2.5% at the open. (dominic.chopping@wsj.com)

(END) Dow Jones Newswires

March 05, 2025 03:30 ET (08:30 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2517998434"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517998434\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2517998434?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 16:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517998434","market":"hk","top_or_hot":-1,"title":"Bayer's Cash Flow Guidance Looks Soft -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. \"We expect a small negative response.\" Shares rise 1.5% after initially dropping as much as 2.5% at the open. (dominic.chopping@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 05, 2025 03:30 ET (08:30 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer's Cash Flow Guidance Looks Soft -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer's Cash Flow Guidance Looks Soft -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-05 16:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. \"We expect a small negative response.\" Shares rise 1.5% after initially dropping as much as 2.5% at the open. (dominic.chopping@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 05, 2025 03:30 ET (08:30 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2517998434","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517998434","pubTimestamp":1741163400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. \"We expect a small negative response.\" Shares rise 1.5% after initially dropping as much as 2.5% at the open. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BAYRY":"Bayer A.G."},"translate_title":"拜耳的现金流指引看起来疲软——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. \"We expect a small negative response.\" Shares rise 1.5% after initially dropping as much as 2.5% at the open. (dominic.chopping@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 03:30 ET (08:30 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}